Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism — Paweł Mróz (2007) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism
Shared by
Michael R Hamblin
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism
Article
2007
en
Authors
+5 more
PM
Paweł Mróz
AP
Anna Pawlak
MS
Minahil Satti
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2018
Comparison of two functionalized fullerenes for antimicrobial photodynamic inactivation: Potentiation by potassium iodide and photochemical mechanisms
Liyi Huang
,
Brijesh Bhayana
,
Weijun Xuan
,
Richard P. Sanchez
,
Billy J. McCulloch
,
Sanjiv Lalwani
,
Michael R Hamblin
Chapter in a book
2015
Photodynamic Therapy of Infectious Disease Mediated by Functionalized Fullerenes
Zeyd Issa
,
Michael R Hamblin
Article
2016
Use of fluorescent probes for ROS to tease apart Type I and Type II photochemical pathways in photodynamic therapy
María García-Díaz
,
Ying‐Ying Huang
,
Michael R Hamblin
Article
2010
Fullerenes in Photodynamic Therapy of Cancer
Paweł Mróz
,
Ying‐Ying Huang
,
Tim Wharton
,
Michael R Hamblin
Article
2021
A Feasible Strategy of Fabricating Type I Photosensitizer for Photodynamic Therapy in Cancer Cells and Pathogens
Kongqi Chen
,
Ping He
,
Zhiming Wang
,
Ben Zhong Tang
Discussion(0)
No comments yet. Be the first to comment.